Roctavia held promise of treating hemophilia A, but has only been used for one patient since its approval in June 2023, Bloomberg reported Feb. 20.
Read the full post on Becker's Hospital Review | Healthcare News & Analysis
Buzz for gene therapies is loud, but drugmakers struggle to get treatments off the ground
